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Abstract
Background:  Nuclear objects that have in common the property of being recognized by
monoclonal antibodies specific for phosphoprotein epitopes and cytoplasmic intermediate
filaments (in particular, SMI-31 and RT-97) have been reported in glial and neuronal cells, in situ and
in vitro. Since neurofilament and glial filaments are generally considered to be restricted to the
cytoplasm, we were interested in exploring the identity of the structures labeled in the nucleus as
well as the conditions under which they could be found there.
Results:  Using confocal microscopy and western analysis techniques, we determined 1) the
immunolabeled structures are truly within the nucleus; 2) the phosphoepitope labeled by SMI-31
and RT-97 is not specific to neurofilaments (NFs) and it can be identified on other intermediate
filament proteins (IFs) in other cell types; and 3) there is a close relationship between DNA
synthesis and the amount of nuclear staining by these antibodies thought to be specific for
cytoplasmic proteins. Searches of protein data bases for putative phosphorylation motifs revealed
that lamins, NF-H, and GFAP each contain a single tyrosine phosphorylation motif with nearly
identical amino acid sequence.
Conclusion: We therefore suggest that this sequence may be the epitope recognized by SMI-31
and RT-97 mABs, and that the nuclear structures previously reported and shown here are likely
phosphorylated lamin intermediate filaments, while the cytoplasmic labeling revealed by the same
mABs indicates phosphorylated NFs in neurons or GFAP in glia.
Background
Objects in nuclei recognized by antibodies specific for
phosphoprotein epitopes, cytoplasmic IFs, or both, have
been reported in glial and neuronal cells, in situ and in vit-
ro. The nuclear structures appear spherical or rod-like and
may have a positional relationship with nuclear pores [1–
4]. Morphologically, these structures appear similar to the
nuclear "speckles" that are thought to be storage sites for
RNA splicing factors [5–7]. However, while intermediate
filament (IF) phosphoproteins could be components of
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nuclear speckles, they are immunologically distinct. In-
vestigations of intermediate filaments (IF) in the nucleus
have focused on lamins (see Goldman for a current re-
view) [8], but many reports of in situ nuclear localization
of cytoplasmic IFs also exist, e.g., vimentin in association
with nuclear DNA in cultured fibroblasts [9,10], and an
estrogen-sensitive cytokeratin association with nuclear
DNA in human breast cancer cells [11].
In a recent study, Glass et al. [12], using the SMI-31 mon-
oclonal antibody (mAB) to identify phosphorylated neu-
rofilament proteins, reported discrete SMI-31 labeling
within nuclei of SH-SY5Y neuroblastoma cells. SH-SY5Y
cells are a subclone of the SK-N-SH human neuroblasto-
ma cell line derived from neoplastic neural crest cells and
under certain growth conditions, generate neuritic proc-
esses [12,13]. Sternberger and Sternberger [14] describe
SMI-31 mAB as specific for phosphorylated epitopes on
the heavy neurofilaments peptide (NF-H) and to a lesser
extent medium neurofilament peptide (NF-M). The RT-97
mAB [9] has been characterized as recognizing phosphor-
ylated epitopes on the 210 kDa NF-H peptide [15], and
used similarly to SMI-31 to identify neurites in vitro and in
situ [16–18]. One would predict, therefore, that labeling
with RT97 would produce staining patterns, including nu-
clear, similar to those of SMI-31 in SH-SY5Y cells.
The nuclear localization of RT-97 and SMI-31 mAB could
be the result of an association of phosphorylated NFs with
nuclear components. Alternatively, it could be that lamins
or other nuclear proteins have a phosphorylated epitope
also found on NFs. For example, Schilling et al. [1] identi-
fied nuclear structures using SMI-31 mAB in rat glial nu-
clei in vitro and in vivo, and Shea et al. [19] showed both
SMI-31 and RT-97 strongly labeled nuclei of NB2a neu-
roblastoma cells. Herrera [20] demonstrated nuclear lo-
calization patterns, similar to those obtained by Glass et
al. [12], using rat glioma cells (9L) immunolabeled with
the J1-31 mAB, which appears to recognize a phosphor-
ylated form of GFAP [21,22].
These observations prompted us to further investigate nu-
clear antigens in SH-SY5Y neuroblastoma cells and to at-
tempt to determine the relationship between these
nuclear objects and cellular growth dynamics. We asked
the following questions: 1) are the immuno-labeled struc-
tures within the nucleus or just closely associated; 2) is the
phosphoepitope labeled by SMI-31 and RT-97 mABs spe-
cific to NFs or can it be identified on other IFs in other cell
types; and 3) is there a relationship between the cell cycle
as determined by DNA synthesis and the amount of nu-
clear labeling by SMI-31 and RT-97?
Results
The immunolabeled structures are within the nucleus
As visualized by confocal microscopy, the SMI-31 and RT-
97 mABs labeled discrete locations apparently within nu-
clei and revealed a filamentous network in the cytoplasm.
(Figure 1A,1B). The nuclear structures were clearly seen to
be located seen within nuclei when visualized by confocal
z-projections, and this location was confirmed by demon-
strating mAB staining and DNA in single optical planes
300 nm thick. The nuclei were found to be 3 to 5 µm
thick, or about 10 to 17 optical section thick. The nuclear
structures were also found to co-localize with nuclear
DNA using the co-localization function of the Bio-Rad La-
serSharp software (data not shown). Therefore, within the
limits of resolution of confocal microscopy, SMI-31 mAB
and RT-97 mAB label epitopes in SH-SY5Y cells that are
inside the nucleus.
The phosphoepitope labeled by SMI-31 and RT-97 is not 
specific to NFs, and it can be identified on other IFs in oth-
er cell types
SMI-31 mAB labeled F98 rat glioma nuclei and cytoplasm
with equal or greater avidity than in SH-SY5Y cells (Figure
1D). The cytoplasmic staining produced by SMI-31 was
not distinguishable from that produced by anti-GFAP in
the F98 glioma cells (Figure 1F). F98 glioma cells are not
known to express neurofilament protein, and SMI-32, a
mAB characterized as specific for non-phosphorylated
NFs [19], stained the expected cytoplasmic network in SH-
SY5Y cells (Figure 1C) but did not label any structures in
F98 glioma cells (data not shown). Thus, it appears that
SMI-31 recognizes a phosphoepitope that occurs on pro-
teins in addition to NF-H and NF-M, as previously report-
ed (see the Discussion for other reports of SMI-31 staining
glial cells in situ). RT-97 also labeled nuclear and cytoplas-
mic structures in F98 cells (Figure 1E).
Electrophoretic and western analysis of SH-SY5Y and F98
cell extracts corroborated the finding that SMI-31 recog-
nized an epitope on proteins other than NFs. In SH-SY5Y
cell extracts, the SMI-31 and SMI-32 lanes show strong la-
beling of bands corresponding to the MW of NF-H and
NF-M. Additional bands, not seen in the SMI-32 lane, are
present in the SMI-31 and RT-97 lanes between and above
the NF-H and NF-M, and probably represent forms of NF-
M and NF-H with varying degrees of phosphorylation.
SMI-31 and RT-97 also revealed a band or closely spaced
bands at 70 kDa which corresponds approximately to the
MW of lamins. Western analysis using anti-lamin B re-
vealed a similar 70 kDa band in extracts of SH-SY5Y cells,
but no bands were labeled by anti-lamin A/C. Labeled
bands below 65 kDa may represent degradation products
produced during cell extraction. Normal serum controls
were negative (data not shown).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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Figure 1
Immunolocalization of mABs SMI-31, SMI-32, anti-BrdU, and pAB anti-GFAP. A. A micrograph showing a single, confocal image 
plane of SH-SY5Y cells labeled with SMI-31 mAB followed by an Alexa-Fluor-488 conjugated secondary antibody (green). 
Nuclei were revealed by the TO-PRO-3 DNA probe (blue). The green SMI-31 mAB labeling appears as white dots within the 
blue nuclei, and as filamentous green structures in the cytoplasm. B. A single image plane of SH-SY5Y cells grown on glass cov-
erslips and labeled with RT97 mAB followed by an Alexa-Fluor-488 conjugated secondary antibody (green). Nuclei were 
revealed by TO-PRO-3 probe (blue). RT97 mAB labeling appears as white dots in nuclei and as filamentous or clumpy green 
structures in the cytoplasm C. A confocal projection of SH-SY5Y cells grown on glass coverslips and labeled with SMI-32 mAB 
followed by an Alexa-Fluor-488 conjugated secondary antibody (green). Nuclei were revealed by TO-PRO-3 probe (blue). SMI-
32 mAB did not label nuclei but did reveal filamentous green structures in the cytoplasm. D. A confocal projection of F98 rat 
glioma cells grown on glass coverslips and labeled with SMI-31 mAB followed by an Alexa-Fluor-488 conjugated secondary anti-
body (green). Nuclei were revealed by TO-PRO-3 probe (blue). SMI-31 mAB labeling appears as white dots in nuclei and as fil-
amentous green structures in the cytoplasm. Labeling in these cells was so intense that the nuclei appeared completely full of 
the labeled epitope. E. A confocal projection of F98 rat glioma cells grown on glass coverslips and labeled with RT97 mAB fol-
lowed by an Alexa-Fluor-488 conjugated secondary antibody (green). Nuclei were revealed by TO-PRO-3 probe (blue). SMI-31 
mAB labeling appears as white dots in nuclei. RT97 staining of nuclear and cytoplasmic structures in F98 rat glioma cells was 
similar but less intense than seen with SMI-31 on F98 cells. F. A confocal projection of F98 cells grown on glass coverslips and 
labeled with anti-GFAP polyclonal AB followed by an Alexa-Fluor-488 conjugated secondary antibody (green). Nuclei were 
revealed by TO-PRO-3 probe (blue). The anti-GFAP revealed the expected filamentous green structures in the cytoplasm but 
did not label structures in nuclei. The white areas that look as if they are in the nucleus are actually green staining in the cyto-
plasm below (seen through) the blue nucleus. G, H, I. Confocal projections of SH-SY5Y cells showing nuclei labeled with TO-
PRO-3 (blue) and anti-BrdU (green, white when co-localized with blue). These panels show nuclei of cells in culture for 1, 3, 
and 6 days, respectively. Labeling intensity appeared to decline as the culture became confluent, suggesting a corresponding 
decline in DNA synthesis and cells exiting the cell cycle. See also Figure 4. *the calibration bar in each panel represents 5 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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Western analysis with anti-GFAP pAB, SMI-31 mAB, RT-
97 mAB, and anti-lamins mAB was performed on F98 cell
extracts subjected to SDS-PAGE. The anti-GFAP lane
shows a strong band at the expected MW, and multiple
bands above it as well as minor bands below. The higher
MW bands most likely represent GFAP multimers, while
the lower MW bands are possibly degradation products.
Multiple bands also appear in both the SMI-31 and RT-97
lanes, although for the most part the antibodies do not
appear to label the same bands. In lanes labeled with SMI-
31, RT-97 or anti-lamin B, a weak but well defined band
Figure 2
Western analysis with SMI-31, RT97, anti-lamin B, SMI-32 on SH-SY5Y, and SMI-31, RT97, anti-lamin B, anti-GFAP on F98 cell 
extracts subjected to SDS-PAGE. On SH-SY5Y, the SMI-31 and SMI-32 lanes show strong labeling of bands corresponding to 
the MW of NF-H, and NF-M. Additional bands, not seen in the SMI-32, are present in the SMI-31 and RT97 lanes between and 
above the NF-H and NF-M, and probably represent phosphorylated forms of NF-M and NF-H. SMI-31, RT-97 and anti-lamin B 
also revealed a band or closely spaced bands at approximately 70 kD which corresponds approximately to the MW of lamin B. 
Western analysis with anti-lamin A/C revealed no bands in either SH-SY5Y or F98 extracts (not shown). On F98 cells, SMI-31 
labeled several well defined bands, including those of MW corresponding to GFAP and lamin B. The RT97 mAB also strongly 
labeled several F98 bands, including bands corresponding to GFAP and lamin B. The anti-lamin B mAB strongly labeled bands at 
the appropriate MW (~70 kD) and also a cluster of bands in the range of the heavy NF MW (~207 kD). The anti-GFAP pAB 
labeled a band at the appropriate MW (~52 kD) and also band higher of MW appropriate for multimers of GFAP (~100, 150, 
200 kD). Labeled bands lower than 65 kD may represent degradation products produced during cell extraction. Negative con-
trols (control blots stained with appropriate normal serum) showed no labeling (data not shown).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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appears at approximately 70 kDa (Figure 2). Controls
(normal mouse serum) were negative (data not shown).
Numerous putative phosphorylation motifs were identi-
fied in the amino acid sequences of NF-H, GFAP and nu-
clear lamins A, B, and C when analyzed by the NetPhos
server, including a single tyrosine kinase motif, LNDRF-
AGYIDKVR, found in the N-terminal region of all five pro-
teins (see Figure 3). In addition, 74 putative serine (=
0.99), 26 threonine (= 0.9) and 7 other tyrosine (= 0.5)
phosphorylation sites were identified; however, only the
tyrosine phosphorylation site shown was shared among
the five proteins analyzed. Therefore it is possible that this
sequence constitutes or contains the epitope recognized
by the SMI-31 and RT-97 mABs, and may account for the
cross-reactivity of these antibodies with respect to NF-H,
GFAP, and lamins.
DNA synthesis and the volume and intensity of nuclear la-
beling are related
Analyses of nuclear labeling intensity and comparison to
proliferation index as a function of days in culture re-
vealed a strong correlation. Comparison of nuclear labe-
ling of SH-SY5Y cells immuno-stained with SMI-31 and
RT-97 mABs to the culture proliferation index shows that
nuclear labeling reached its greatest extent when DNA
synthesis was also maximal. Both values fell as cells exited
the cell cycle as indicated by lack of BrdU uptake, and by
day 5, when the cultures appear confluent, essentially all
cell replication had stopped (see Figure 1G,1H,1I and Fig-
ure 4).
Discussion
SH-SY5Y cells immunolabeled with SMI-31 mAB or RT-97
mAB demonstrated discrete nuclear localizations in nuclei
with pronounced staining in neuronal processes and dif-
fuse staining within cell bodies. Confocal microscopy
demonstrated clearly that the antibodies label structures
within the nucleus. Comparison among antibodies that
are specific for phosphorylated IFs (SMI-31, RT-97) and
those not (SMI-32, anti-GFAP) suggests that the nuclear
structures are a phosphorylated IF. Cross reactivity of both
SMI-31 and RT-97 on glial cytoplasm and nuclei indicates
the epitope is not cell type specific. Examination of west-
ern blots indicate SMI-31 and RT-97 recognize, among
others, a protein in the 66 – 74 kDa range in extracts of
both neuroblastoma and glioma cells. Western analysis
with anti-lamin B labeled a similar band in the same ex-
tracts. The calculated molecular weights of lamins A, B
and C are approximately 74, 66, and 65 kDa, respectively;
therefore, it seems most likely that lamins, NF-H, and
GFAP all share a common motif that, when phosphorylat-
ed, is recognized by SMI-31 and RT-97 mABs. In support
of this, a search for phosphorylation motifs among NF-H,
GFAP and lamins A, B, and C revealed a single, high prob-
ability tyrosine site that occurs once on each of these pro-
teins (Figure 3), further suggesting the possibility that this
site constitutes or is contained within the epitope recog-
nized by these two antibodies.
Based on the finding of a shared, tyrosine phosphoryla-
tion site, it seems likely that the nuclear structures
reported in this and previous studies [1,12] that employed
SMI-31 are phosphorylated lamins. Furthermore, nuclear
labeling and DNA synthesis appeared tightly associated in
Figure 3
A portion of the amino acid sequences for NF-H, GFAP, and lamin A, B, and C. The Match-Box server prints aligned sequences 
in lower case, an unaligned as uppercase. The numbers printed below each column of aligned amino acids indicates the reliabil-
ity of the alignment, where 1 = 10%, 3 = 20%, and 5 = 50% chance of equal occurrence in related or unrelated sequences (low 
scores are best, Depiereux et al, 1997). While we found many phosphorylation motifs in the sequences examined, the indicated 
tyrosine kinase motif was the only one shared with a high degree of identity among all 5 sequences. As it occurs only once, the 
remainder of the sequences are not shown. The darker gray shading indicates the predicted motif for NF-H (the reference 
sequence), while the light gray shows regions of GFAP and lamins that include the tyrosine (bold-face "Y") in a motif with very 
high sequence identity.
              80        90       100       110       120       130       140
NF-H  asstdsLDTLSNGPEGCMVavatsrsekeqlqalndrfagyidkvrqleahnrslegeaaALR-------
GFAP  lnag---------------fketraseraemmelndrfasyiekvrfleqqnkalaaelnQLRAKEPTKL
LamA  qasstpLSP----------tritrlqekedlqelndrlavyidrvrsletenaglrlritESEEVVSREV
LamB  pttplsP------------trlsrlqekeelrelndrlavyidkvrsletensalqlqvtEREEVRGREL
LamC  qasstpLSP----------tritrlqekedlqelndrlavyidrvrsletenaglrlritESEEVVSREV
      888888             88855555553333111111111333333333355558888BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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SH-SY5Y cultures, consistent with the suspected role of
lamins in DNA replication [8]. Others have reported SMI-
31 labeling in glial as well as neuronal nuclei. For exam-
ple, Schilling et al. [1] identified developmentally regulat-
ed nuclear antigens recognized by SMI-31 mAB in C6 rat
glioma cells in vitro as well as glial and neuronal nuclei in
vivo, suggesting the presence non-neurofilament epitopes.
In addition, Shea et al. [19], in a study of neurite out-
growth from NB2a cells, showed that both the SMI-31 and
RT-97 mABs strongly labeled nuclei of undifferentiated
cells, and the nuclear labeling declined as differentiation
progressed. These results are similar to the results reported
here. In a recent paper by Glass et al. [12], SMI-31 was de-
scribed as labeling nuclear epitopes in cells in culture and
in neurons of mature rat brain as visualized by cryo-sec-
tioning and confocal microscopy. However, in light of the
findings reported here, the nuclear objects reported by
Glass et al. in rat brain sections may have been in mitoti-
cally active glial cells as well as in neurons.
Although these nuclear epitopes appear similar to nuclear
speckles, the latter have not been reported as IF-associated
structures, but rather storage sites of RNA processing pro-
teins (see Sanford 2002, for a current, brief review [5]).
However, as it is know that lamins are involved in nucleo-
skeletal organization [23] and organization of DNA repli-
cation sites [4], it would not be unexpected to find lamins
Figure 4
Graph showing a strong correlation between the culture proliferation index (percent nuclei showing BrdU incorporation) and 
the extent of nuclear labeling as a function of days in culture for SH-SY5Y cells immuno-stained for SMI-31, RT97. Values for 
SMI-31 and RT-97 labeling represent averages (± SEM) of the percentage of nuclear area labeled as determined by confocal 
projection. Proliferation index data is shown through day 5 and 6 to illustrate that the culture enters a confluent, stationary 
phase. See also Figure 1G,1H and 1I.
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associated with nuclear speckles, perhaps as structural
organizers.
Conclusions
Both RT-97 and SMI-31 may recognize the phosphorylat-
ed tyrosine motif, LNDRFAGYIDKVR, which occurs in NF-
H and thus provides the basis for the claim of these anti-
bodies being specific for phosphorylated NFs [14]. How-
ever, this same motif occurs in GFAP and lamins A, B, and
C and possibly other proteins, and is not restricted to
neurons as shown by the glial staining reported here and
in other studies [1]. It would be interesting to look at nu-
clei from a variety of tissue types using these antibodies as
probes.
In this study and in previous studies performed in other
laboratories [1,19], a close relationship between the nu-
clear phosphoepitopes and growth phase has been report-
ed. Because of the association of phosphorylated lamins
with DNA replication and the cell cycle [8], and the
sharing of phosphoepitopes among lamins, NFs, and
GFAP, it seems most probable that the nuclear epitopes re-
vealed in neuroblastoma and glioma cells by SMI-31 and
RT-97 are contained on lamin B.
Methods
Preparation and Maintenance of Cell Cultures
All culture reagents were obtained from Sigma, St. Louis,
MO, unless otherwise noted. SH-SY5Y cells were main-
tained in culture as previously described [12]. Initial cell
density was determined using a hemacytometer (Fisher
Scientific, Pittsburgh, PA) and diluted appropriately to
maintain a seeding density of 4.0 × 104 cells/cm2 of sur-
face area. Cells were grown for approximately 72 hours
and fixed in cold methanol unless otherwise indicated.
F98 rat glioma cells (ATCC, http://www.atcc.org/, Manas-
sas, VA) were also used for comparative purposes in this
study, and were cultured as described for SH-SY5Y cells.
Fixation and Immunofluorescence Staining for Confocal 
Microscopy
Cells grown on coverslips were washed briefly in a phos-
phate-buffered saline (PBS) solution (pH 7.4, 137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4)
and then either fixed in 100% methanol at -20°C for 1
minute or at room temperature in a 4% formaldehyde
(PFA) solution freshly made from paraformaldehyde
(Electron Microscopy Sciences, Ft. Washington, PA) and
buffered with PBS (or PBS with 0.2% Tween-20, PBST) for
10 minutes followed by 3 washes in PBS/PBST for 10 min-
utes each. As a previous study [13] had suggested nuclear
staining by antibodies targeted to cytoplasmic proteins
might be fixation dependent [4] or an artifact of fixation,
we did a preliminary comparison of SMI-31 labeling of
methanol vs. paraformaldehyde fixed cells. We found mi-
nor differences in the staining pattern between methanol
and paraformaldehyde fixed cells, but immuno-labeled
nuclear structures were visible regardless of fixation. No
differences in the localization of mAB staining in the cells
was noted when comparing between the two methods of
fixation.
After fixation the cell-bearing coverslips were incubated in
20% non-fat powdered milk in PBS to block non-specific
protein-protein interactions for 2 hours at room
temperature. The coverslips were then washed 3 times, 10
minutes each, and incubated with the desired primary an-
tibody (Table 1) for 16–24 hours at 4°C. The cells were
again washed three times in PBS (10 minutes each) and
incubated with the appropriate secondary antibody (Ta-
ble 2) for 2 hours at room temperature. During the final
30 minutes of secondary antibody incubation 40 µl of
TO-PRO-3 (T-3605, Molecular Probes, Eugene, OR), a
DNA specific probe was added for identification of nuclei
(Table 1). Negative controls for all immuno-preparations
were prepared by use of the appropriate normal serum in
place of the primary antibody. The coverslips were then
mounted on glass slides in a medium consisting of 90%
glycerol in water containing 1 mg/ml p-phenylenedi-
amine, and stored at -20°C in the dark.
Microscopy and Quantitative Analysis of Immunolabeling
An Olympus IX-70 fitted with a Bio-Rad MRC 1024 con-
focal scanhead via the Keller port was used for all image
acquisition. Initial image processing was done using Bio-
Rad LaserSharp software running on a Compaq PC; final
processing and printing of images was done using Adobe
Photoshop 7.0 software.
Culture dynamics were determined for SH-SY5Y neurob-
lastoma cells at an initial density of 4.0 × 104 cells/cm2.
Cells were introduced into five 25 cm2 flasks, then har-
vested from one flask each day using 5 ml Puck's saline so-
lution (pH 7.3, 137 mM NaCl, 5.4 mM KCl, 0.7 mM
Na2HPO4, 9.5 mM HEPES, 5.6 mM dextrose, and 0.8 mM
EDTA). Detached cells were pelleted at 2500 rpm for 5
minutes in a clinical centrifuge and resuspended in 2 ml
of PBS. Cell density was determined each day by counting
the number of cells present in representative samples us-
ing a two-chambered hemacytometer. A proliferation
index was calculated as the percentage of nuclei present
engaged in DNA synthesis, using BrdU uptake as an indi-
cator (see part D below for BrdU labeling method; also see
Figure 4).
Quantitation of fluorescent labeling was performed on
confocal images collected using calibrated microscope
channel settings for cells grown 1–5 days. All images were
collected from cells stained at the same time with the
same batch of antibody. Thus any differences in stainingBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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intensity and area stained were expected to be a function
of time in culture and/or culture density. This entire proc-
ess was performed in duplicate.
Confocal stacks were projected and then imported into
NIH Image 1.6 software (freeware at http://rsb.in-
fo.nih.gov/nih-image/). Density slice filtering was used to
remove background autofluorescence and then record the
area stained in each nucleus in the flattened image. Inten-
sity values above background were also determined, but
not used as they were found insensitive to growth condi-
tions and more sensitive to nuclear thickness (the number
of optical sections in the projected stack) than to experi-
mental parameters. The area per nucleus stained is not af-
fected by the number of sections in the projected stack,
and was significantly related to culture conditions. These
data were used to relate nuclear area stained to time in
culture. Statistical analysis was done using linear regres-
sion and single factor analysis of variance (ANOVA).
Identification of Actively Growing Cells using 5-Bromo-2'-
Deoxyuridine
Cells were seeded onto glass coverslips at an initial density
of 4.0 × 104 cells/cm2 and allowed to grow for 1–5 days.
Twenty-four hours prior to fixation, the cells were incu-
bated with 10 µM 5-bromo-2'-deoxyuridine in MEM (see
Table 1). At the appropriate time, the cells were fixed in
methanol at -20°C for 1–2 minutes, allowed to air dry,
then stored at -20°C until all coverslips were ready for
processing. The cells were rehydrated in PBS for 5 minutes
followed by immersion in 2N HCl for 1 hour at room
temperature. The cells were incubated in 0.1 M borate
buffer (pH 8.5, 0.1 M boric acid, 25 mM Na2B4O7, and 75
mM NaCl) twice for 5 minutes each (10 minutes total),
followed by three 10 minute washes in PBS. Next, cells
were immunolabeled using anti-BrdU monoclonal mouse
IgG primary antibody followed by goat anti-mouse IgG
conjugated to Alexa-Fluor 488 (see Tables 1 and 2). All an-
tibody incubations were 1 hour at room temperature in
reduced light. During the final 30 minutes of secondary
antibody incubation TO-PRO-3 nucleic acid stain
(Molecular Probes) was added at a 1:1000 dilution. The
coverslips were then washed and mounted for microscop-
ic analysis. The intensity and area/nucleus of BrdU labe-
ling was quantitated as described above for
immunolabeling.
Table 1: Primary antibodies.
Antibody Species/Isotype Dilution for 
Fluorescence
Dilution for Western 
Analysis
Supplier
Anti-BrdU mAB Mouse IgG 1:400 in PBS Molecular Probes, Eugene, OR 
(#A-21300)
Anti-GFAP pAB Rabbit IgG 1:86 in PBS 1:400 in PBS Sigma Chem. Co., St. Louis, MO 
(#G-9269)
Anti-lamin A/C mAB Mouse IgG 1:500 Chemicon International, Temecula 
CA (MAB3538)
Anti-lamin B mAB Mouse IgG 1:500 Chemicon International, Temecula 
CA (MAB3536)
Anti-neurofilament, RT-97 Mouse IgG Undiluted culture 
supernatant
Undiluted culture 
supernatant
Developmental Studies Hybrid-
oma Bank at the University of 
Iowa, Iowa City, IA
Anti-nonphospho-neurofilament, 
SMI-32 mAB
Mouse IgG1 1:1000 in PBS 1:1000 in PBS Sternberger Monoclonals, Inc. 
Lutherville, MD
Anti-phospho-neurofilament, SMI-31 
mAB
Mouse IgG1 1:1000 in PBS 1:2000 in PBS Sternberger Monoclonals, Inc., 
Lutherville, MD
Table 2: Secondary antibodies and probes used for immunofluorescence and western blot analysis.
Antibody/Probe (Catalog #) Conjugate Dilution Supplier
Goat anti-mouse IgG (#A-11001) Alexa-fluor 488 1:200 in PBS Molecular Probes, Eugene, OR
Goat anti-rabbit IgG (#T-6778) Alexa-fluor 488 1:200 in PBS Molecular Probes, Eugene, OR
Goat anti-mouse polyvalent (#A-0162) Alkaline Phosphatase 1:4000 in PBS Sigma Chem. Co, St. Louis, MO
Goat anti-rabbit IgG (#A-3812) Alkaline Phosphatase 1:30,000 in PBS Sigma Chem. Co., St. Louis, MO
Nucleic Acid binding probe; TO-PRO-3 iodine (#T-3605) --- 1:1000 in PBS Molecular Probes, Eugene, ORBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/6
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Preparation of Total Cell Lysates, Electrophoresis and 
Western Blot Analysis
Cells were seeded at an initial density of 4.0 × 104 cells/
cm2 and grown in 150 cm2 flasks for 2 days. MEM was re-
moved and cells were detached from the substrate using
10 ml Puck's saline solution and incubated at 37°C for 5
minutes. The detached cells were transferred to a centri-
fuge tube and spun at 2500 rpm for 5 minutes. The pellet
was resuspended in 5 volumes of 2 × sample buffer (60
mM Tris-HCl, 25% glycerol, 2% SDS, 14.4 mM 2-mercap-
toethanol, 0.1% bromphenol blue, and 1 mM EGTA) then
diluted 1:1 in PBS. Samples were incubated in boiling wa-
ter for 5 minutes then passed through a 20-gauge and 26-
gauge needle repeatedly to shear chromosomal DNA. The
lysates were centrifuged at 4000 × g for 15 minutes, then
aliquoted and stored at -20°C prior to sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and western analysis as previously described [12]. Protein
concentrations of the cell lysates were determined using
the Bio-Rad Protein Assay (Hercules, CA), and sample vol-
umes adjusted so that 5–10 µg of total protein were load-
ed into wells of a discontinuous (12% separating, 4%
stacking) polyacrylamide gel. Gels were prepared in dupli-
cate and one of each pair stained in Coomassie blue and
the other used for electrophoretic transfer onto a nitrocel-
lulose membrane (Bio-Rad, Hercules, CA). The identities
of the proteins bound to the nitrocellulose membrane
were revealed using the appropriate primary and second-
ary antibodies (Tables 1 and 2). Molecular weight values
were determined by calculating Rf ratios as the distance
from the bottom of the well to the protein band of interest
divided by the distance from the bottom of the well to the
dye front. Standard curves were developed using log MW
of protein standards versus Rf ratio of those standards. Ap-
parent molecular weights of proteins identified by west-
ern blot analysis were determined by extrapolating MW
from the standard curve using measured Rf ratios.
Identification of Consensus Phosphorylation Motifs in IF 
proteins
Amino acid sequences for human NF-H (Accession QF-
HUH), lamin A/C (Accession P02545), and B (Accession
P20700), and human GFAP (Accession XP_050159) were
obtained from the National Center for Biotechnology In-
formation Protein Data Base http://www.nc-
bi.nlm.nih.gov:80/entrez/query.fcgi?db=Protein. These
were searched for potential phosphorylation sites using
PhosphoBase v2.0 http://www.cbs.dtu.dk/databases/
PhosphoBase/, a Web based analysis tool provided by the
Center for Biological Sequence Analysis, BioCentrum-
DTU, Technical University of Denmark [24]. The five ami-
no acid sequences were aligned to NF-H using the Match-
Box server located on the Internet at http://
www.fundp.ac.be/sciences/biologie/bms/
matchbox_submit.html. Amino acid sequences predicted
by PhosphoBase as serine, threonine, or tyrosine phos-
phorylation motifs for NF-H were then compared to the
aligned proteins in regions of high identity, as determined
by reliability scores generated by the Match-Box server
[25].
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